Literature DB >> 19713854

The role of cytokines in cancer cachexia.

Josep M Argilés1, Sílvia Busquets, Miriam Toledo, Francisco J López-Soriano.   

Abstract

PURPOSE OF REVIEW: The present investigation is devoted to uncovering the different signaling pathways - particularly transcriptional factors - involved in muscle wasting. RECENT
FINDINGS: Although the search for the cachectic factor(s) started a long time ago, and although many scientific and economic efforts have been devoted to its discovery, we are still a long way from knowing the whole truth. In this review we describe recent findings about the tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, TWEAK and myostatin actions in cancer cachexia models.
SUMMARY: The main aim of the present review is to summarize and evaluate the different molecular mechanisms and catabolic mediators (mainly cytokines) involved in cancer cachexia since they may represent targets for future promising clinical investigations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713854     DOI: 10.1097/SPC.0b013e3283311d09

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  79 in total

1.  JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Authors:  Andrea Bonetto; Tufan Aydogdu; Xiaoling Jin; Zongxiu Zhang; Rui Zhan; Leopold Puzis; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

2.  Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers.

Authors:  Tanios Bekaii-Saab; Mitch A Phelps; Xiaobai Li; Motoyasu Saji; Laura Goff; John Sae Wook Kauh; Bert H O'Neil; Stephanie Balsom; Catherine Balint; Ryan Liersemann; Vasily V Vasko; Mark Bloomston; William Marsh; L Austin Doyle; Gilian Ellison; Michael Grever; Matthew D Ringel; Miguel A Villalona-Calero
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

3.  Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.

Authors:  Ashwani Mittal; Shephali Bhatnagar; Akhilesh Kumar; Pradyut K Paul; Shihuan Kuang; Ashok Kumar
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 4.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

5.  Rel A/p65 is required for cytokine-induced myotube atrophy.

Authors:  Takuo Yamaki; Chia-Ling Wu; Michael Gustin; Jamie Lim; Robert W Jackman; Susan C Kandarian
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-16       Impact factor: 4.249

6.  Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities.

Authors:  Erin E Talbert; Jennifer Yang; Thomas A Mace; Matthew R Farren; Alton B Farris; Gregory S Young; Omar Elnaggar; Zheng Che; Cynthia D Timmers; Priyani Rajasekera; Jennifer M Maskarinec; Mark Bloomston; Tanios Bekaii-Saab; Denis C Guttridge; Gregory B Lesinski
Journal:  Mol Cancer Ther       Date:  2016-11-03       Impact factor: 6.261

Review 7.  TWEAK and TRAF6 regulate skeletal muscle atrophy.

Authors:  Ashok Kumar; Shephali Bhatnagar; Pradyut K Paul
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-05       Impact factor: 4.294

8.  TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.

Authors:  Shephali Bhatnagar; Ashwani Mittal; Sanjay K Gupta; Ashok Kumar
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

Review 9.  Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.

Authors:  Lu Miao; Aaron K Holley; Yanming Zhao; William H St Clair; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2014-01-22       Impact factor: 8.401

10.  Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.

Authors:  Tomoya Fukawa; Benjamin Chua Yan-Jiang; Jason Chua Min-Wen; Elwin Tan Jun-Hao; Dan Huang; Chao-Nan Qian; Pauline Ong; Zhimei Li; Shuwen Chen; Shi Ya Mak; Wan Jun Lim; Hiro-Omi Kanayama; Rosmin Elsa Mohan; Ruiqi Rachel Wang; Jiunn Herng Lai; Clarinda Chua; Hock Soo Ong; Ker-Kan Tan; Ying Swan Ho; Iain Beehuat Tan; Bin Tean Teh; Ng Shyh-Chang
Journal:  Nat Med       Date:  2016-05-02       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.